NTLA
Intellia Therapeutics, Inc.
+1.09 (+9.49%)12.58USD3.2M成交股數1.8B市值–本益比(近四季)29.6股價營收比-46.2%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 5 · 507K · 3 |
| 其中 10b5-1 計畫賣出 | 3 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 507K |
| 近 180 天 淨額 | −507K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-21 | 08-24 | LEONARD JOHN M | President and CEO | S 公開市場賣出(10b5-1) | 2.8K | 13.00 | 36K | 1.1M | SEC |
| 2026-08-20 | 08-24 | LEONARD JOHN M | President and CEO | S 公開市場賣出(10b5-1) | 19.9K | 12.60 | 251K | 1.1M | SEC |
| 2026-07-22 | 07-24 | Dulac Edward J III | EVP, Chief Financial Officer | S 公開市場賣出 | 8.1K | 11.25 | 91K | 148K | SEC |
| 2026-07-02 | 07-06 | Dulac Edward J III | EVP, Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.7K | 18.00 | 84K | 156K | SEC |
| 2026-07-01 | 07-06 | Dube Michael P | VP, Chief Accounting Officer | S 公開市場賣出 | 2.6K | 16.78 | 44K | 66.9K | SEC |
| 2026-06-09 | 06-10 | Cohen Fred E | Director | A 獲配股票 | 9.2K | – | – | 217K | SEC |
| 2026-06-09 | 06-10 | GOODMAN JESSE | Director | A 獲配股票 | 9.2K | – | – | 33.6K | SEC |
| 2026-06-09 | 06-10 | Goff Brian | Director | A 獲配股票 | 9.2K | – | – | 32.6K | SEC |
| 2026-06-09 | 06-10 | CHASE WILLIAM J | Director | A 獲配股票 | 9.2K | – | – | 144K | SEC |
| 2026-06-09 | 06-10 | Verwiel Frank | Director | A 獲配股票 | 9.2K | – | – | 35.1K | SEC |
| 2026-06-09 | 06-10 | Keresty Georgia | Director | A 獲配股票 | 9.2K | – | – | 41.1K | SEC |
| 2026-06-09 | 06-10 | Bhanji Muna | Director | A 獲配股票 | 9.2K | – | – | 36.4K | SEC |
| 2026-03-02 | 03-03 | BASTA JAMES | EVP, General Counsel | S 公開市場賣出 | 1.2K | 13.78 | 17K | 157K | SEC |
| 2026-03-02 | 03-03 | Clark Eliana | EVP, Chief Technical Officer | S 公開市場賣出 | 607 | 13.78 | 8K | 93.9K | SEC |
| 2026-03-01 | 03-03 | LEONARD JOHN M | President and CEO | A 獲配股票 | 156K | – | – | 1.2M | SEC |
| 2026-03-01 | 03-03 | Clark Eliana | EVP, Chief Technical Officer | A 獲配股票 | 7.4K | – | – | 94.5K | SEC |
| 2026-03-01 | 03-03 | Schultes Birgit C | EVP, Chief Scientific Officer | A 獲配股票 | 39.2K | – | – | 138K | SEC |
| 2026-03-01 | 03-03 | Dube Michael P | VP, Chief Accounting Officer | A 獲配股票 | 17.3K | – | – | 69.5K | SEC |
| 2026-03-01 | 03-03 | BASTA JAMES | EVP, General Counsel | A 獲配股票 | 46.1K | – | – | 158K | SEC |
| 2026-03-01 | 03-03 | Lebwohl David | EVP, Chief Medical Officer | A 獲配股票 | 9.9K | – | – | 131K | SEC |
| 2026-03-01 | 03-03 | Dulac Edward J III | EVP, Chief Financial Officer | A 獲配股票 | 61.3K | – | – | 161K | SEC |
| 2026-01-05 | 01-07 | LEONARD JOHN M | President and CEO | S 公開市場賣出 | 34.1K | 9.21 | 314K | 1.0M | SEC |
| 2026-01-05 | 01-07 | Dube Michael P | VP, Chief Accounting Officer | S 公開市場賣出 | 3.0K | 9.21 | 28K | 52.3K | SEC |
| 2026-01-05 | 01-07 | Clark Eliana | EVP, Chief Technical Officer | S 公開市場賣出 | 9.5K | 9.21 | 88K | 87.1K | SEC |
| 2026-01-05 | 01-07 | BASTA JAMES | EVP, General Counsel | S 公開市場賣出 | 10.4K | 9.21 | 96K | 102K | SEC |
| 2026-01-05 | 01-07 | Cohen Fred E | Director | P 公開市場買進 | 150K | 9.35 | 1.4M | 207K | SEC |
| 2026-01-05 | 01-07 | Lebwohl David | EVP, Chief Medical Officer | S 公開市場賣出 | 11.9K | 9.21 | 110K | 121K | SEC |
| 2026-01-05 | 01-07 | Schultes Birgit C | EVP, Chief Scientific Officer | S 公開市場賣出 | 8.5K | 9.21 | 78K | 98.5K | SEC |
| 2026-01-05 | 01-07 | Dulac Edward J III | EVP, Chief Financial Officer | S 公開市場賣出 | 6.4K | 9.21 | 59K | 99.7K | SEC |
| 2025-12-12 | 12-12 | LEONARD JOHN M | President and CEO | M 選擇權執行 | 8.6K | 6.83 | 58K | 1.0M | SEC |
| 2025-12-11 | 12-12 | LEONARD JOHN M | President and CEO | S 公開市場賣出(10b5-1) | 50.0K | 9.49 | 474K | 1.1M | SEC |
| 2025-12-11 | 12-12 | LEONARD JOHN M | President and CEO | M 選擇權執行 | 50.0K | 6.83 | 341K | 1.1M | SEC |
| 2025-12-11 | 12-12 | LEONARD JOHN M | President and CEO | S 公開市場賣出(10b5-1) | 32.8K | 9.47 | 311K | 1.0M | SEC |
| 2025-12-11 | 12-12 | LEONARD JOHN M | President and CEO | S 公開市場賣出(10b5-1) | 5.4K | 9.59 | 51K | 1.0M | SEC |
| 2025-10-01 | 10-03 | Schultes Birgit C | EVP, Chief Scientific Officer | S 公開市場賣出 | 31 | 17.38 | 538.78 | 105K | SEC |
| 2025-10-01 | 10-03 | Dube Michael P | VP, Chief Accounting Officer | S 公開市場賣出 | 1.9K | 17.38 | 33K | 55.3K | SEC |
| 2025-08-20 | 08-22 | CHASE WILLIAM J | Director | P 公開市場買進 | 100K | 10.03 | 1.0M | 135K | SEC |
| 2025-07-23 | 07-25 | Dulac Edward J III | EVP, Chief Financial Officer | S 公開市場賣出 | 7.5K | 14.02 | 105K | 106K | SEC |
| 2025-07-02 | 07-03 | Dube Michael P | VP, Chief Accounting Officer | S 公開市場賣出 | 2.5K | 9.95 | 25K | 57.1K | SEC |
| 2025-07-01 | 07-03 | Clark Eliana | EVP, Chief Technical Officer | S 公開市場賣出 | 1.0K | 9.82 | 10K | 95.4K | SEC |
| 2025-07-01 | 07-02 | GOODMAN JESSE | Director | S 公開市場賣出(10b5-1) | 1.5K | 9.23 | 14K | 24.4K | SEC |
| 2025-06-30 | 07-02 | GOODMAN JESSE | Director | S 公開市場賣出(10b5-1) | 1.5K | 9.56 | 15K | 25.9K | SEC |
| 2025-06-11 | 06-18 | Keresty Georgia | Director | A 獲配股票 | 8.0K | – | – | 31.9K | SEC |
| 2025-06-11 | 06-13 | Cohen Fred E | Director | A 獲配股票 | 8.0K | – | – | 57.5K | SEC |
| 2025-06-11 | 06-13 | Verwiel Frank | Director | A 獲配股票 | 8.0K | – | – | 25.9K | SEC |
| 2025-06-11 | 06-13 | GOODMAN JESSE | Director | A 獲配股票 | 8.0K | – | – | 27.5K | SEC |
| 2025-06-11 | 06-13 | Goff Brian | Director | A 獲配股票 | 8.0K | – | – | 23.4K | SEC |
| 2025-06-11 | 06-13 | Bhanji Muna | Director | A 獲配股票 | 8.0K | – | – | 27.2K | SEC |
| 2025-06-11 | 06-13 | CHASE WILLIAM J | Director | A 獲配股票 | 8.0K | – | – | 34.7K | SEC |
| 2025-04-29 | 05-01 | Bhanji Muna | Director | S 公開市場賣出(10b5-1) | 265 | 8.50 | 2K | 19.2K | SEC |
| 2025-03-04 | 03-04 | Clark Eliana | EVP, Chief Technical Officer | S 公開市場賣出 | 679 | 8.99 | 6K | 95.4K | SEC |
| 2025-03-04 | 03-04 | BASTA JAMES | EVP, General Counsel | S 公開市場賣出 | 2.6K | 8.99 | 23K | 112K | SEC |
| 2025-03-01 | 03-04 | BASTA JAMES | EVP, General Counsel | A 獲配股票 | 40.0K | – | – | 114K | SEC |
| 2025-03-01 | 03-04 | Dulac Edward J III | EVP, Chief Financial Officer | A 獲配股票 | 47.2K | – | – | 114K | SEC |
| 2025-03-01 | 03-04 | Schultes Birgit C | EVP, Chief Scientific Officer | A 獲配股票 | 37.6K | – | – | 105K | SEC |
| 2025-03-01 | 03-04 | Clark Eliana | EVP, Chief Technical Officer | A 獲配股票 | 32.0K | – | – | 96.0K | SEC |
| 2025-03-01 | 03-04 | LEONARD JOHN M | President and CEO | A 獲配股票 | 136K | – | – | 1.1M | SEC |
| 2025-03-01 | 03-04 | Dube Michael P | VP, Chief Accounting Officer | A 獲配股票 | 14.0K | – | – | 59.6K | SEC |
| 2025-03-01 | 03-04 | Lebwohl David | EVP, Chief Medical Officer | A 獲配股票 | 43.2K | – | – | 131K | SEC |
| 2025-01-29 | 01-31 | Bhanji Muna | Director | S 公開市場賣出(10b5-1) | 265 | 9.97 | 3K | 19.5K | SEC |
| 2025-01-03 | 01-07 | Hicks Derek | EVP, Chief Business Officer | S 公開市場賣出 | 6.5K | 12.18 | 79K | 59.9K | SEC |
| 2025-01-03 | 01-07 | LEONARD JOHN M | President and CEO | S 公開市場賣出 | 26.8K | 12.18 | 327K | 941K | SEC |
| 2025-01-03 | 01-07 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S 公開市場賣出 | 9.0K | 12.18 | 109K | 77.4K | SEC |
| 2025-01-03 | 01-07 | BASTA JAMES | EVP, General Counsel | S 公開市場賣出 | 7.1K | 12.18 | 86K | 74.5K | SEC |
| 2025-01-03 | 01-07 | Lebwohl David | EVP, Chief Medical Officer | S 公開市場賣出 | 9.6K | 12.18 | 116K | 87.7K | SEC |
| 2025-01-03 | 01-07 | Dube Michael P | VP, Chief Accounting Officer | S 公開市場賣出 | 1.4K | 12.18 | 17K | 45.6K | SEC |
| 2025-01-03 | 01-06 | Clark Eliana | EVP, Chief Technical Officer | S 公開市場賣出 | 7.4K | 12.18 | 90K | 64.0K | SEC |
| 2025-01-02 | 01-06 | Clark Eliana | EVP, Chief Technical Officer | S 公開市場賣出 | 556 | 12.03 | 7K | 71.5K | SEC |
| 2025-01-01 | 01-03 | LEONARD JOHN M | President and CEO | M 選擇權執行 | 7.8K | – | – | 968K | SEC |
| 2025-01-01 | 01-03 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | M 選擇權執行 | 3.5K | – | – | 86.4K | SEC |
| 2025-01-01 | 01-03 | Lebwohl David | EVP, Chief Medical Officer | M 選擇權執行 | 3.2K | – | – | 97.2K | SEC |
| 2024-10-02 | 10-04 | Dube Michael P | VP, Chief Accounting Officer | S 公開市場賣出 | 2.0K | 19.01 | 38K | 47.0K | SEC |
| 2024-07-22 | 07-24 | Dulac Edward J III | EVP, Chief Financial Officer | A 獲配股票 | 66.3K | – | – | 66.3K | SEC |
| 2024-07-01 | 07-03 | Clark Eliana | EVP, Chief Technical Officer | S 公開市場賣出 | 405 | 22.93 | 9K | 71.5K | SEC |
| 2024-07-01 | 07-03 | Dube Michael P | VP, PAO and Interim PFO | A 獲配股票 | 17.8K | – | – | 49.0K | SEC |
| 2024-06-17 | 06-20 | Verwiel Frank | Director | S 公開市場賣出(10b5-1) | 1.5K | 25.00 | 38K | 17.9K | SEC |
| 2024-06-13 | 06-17 | Goff Brian | Director | A 獲配股票 | 15.4K | – | – | 15.4K | SEC |
| 2024-06-12 | 06-14 | Cohen Fred E | Director | A 獲配股票 | 7.7K | – | – | 49.5K | SEC |
| 2024-06-12 | 06-14 | Bhanji Muna | Director | A 獲配股票 | 7.7K | – | – | 19.7K | SEC |
| 2024-06-12 | 06-14 | CHASE WILLIAM J | Director | A 獲配股票 | 7.7K | – | – | 26.7K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| 方舟(伍德) ARK Investment Management LLC | 16.9M | 286M | 新進 | 新進 |
| BlackRock, Inc. | 15.4M | 261M | 新進 | 新進 |
| STATE STREET CORP | 9.2M | 156M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.3M | 124M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 6.4M | 109M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.0M | 102M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 5.2M | 88.6M | 新進 | 新進 |
| FMR LLC | 4.8M | 80.8M | 新進 | 新進 |
| RA CAPITAL MANAGEMENT, L.P. | 4.5M | 76.6M | 新進 | 新進 |
| REGENERON PHARMACEUTICALS, INC. | 3.7M | 62.7M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.6M | 61.4M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.3M | 55.5M | 新進 | 新進 |
| Sumitomo Mitsui Trust Group, Inc. | 2.9M | 49.0M | 新進 | 新進 |
| Amova Asset Management Americas, Inc. | 2.9M | 49.0M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 2.6M | 44.0M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 2.3M | 38.3M | 新進 | 新進 |
| UBS Group AG | 2.2M | 36.4M | 新進 | 新進 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 2.1M | 35.0M | 新進 | 新進 |
| Contrarius Group Holdings Ltd | 2.0M | 33.1M | 新進 | 新進 |
| JUPITER ASSET MANAGEMENT LTD | 1.8M | 31.3M | 新進 | 新進 |
| MORGAN STANLEY | 1.7M | 29.3M | 新進 | 新進 |
| ARMISTICE CAPITAL, LLC | 1.5M | 25.4M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 1.4M | 23.7M | 新進 | 新進 |
| NORTHERN TRUST CORP | 1.3M | 21.5M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | 20.4M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 329 +23 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 329 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 144M · 100.0% |
| 合計季末市值 | 2.4B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 43.9M |
|---|---|
| 與上期比 | -2.1% |
| 佔流通股數 | 31.35% |
| 日均成交量 | 3.4M |
| 回補天數 | 12.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 43.9M | -2.1% | 31.35% | 3.4M | 12.9 |
| 2026-08-14 | 44.9M | +2.0% | 32.03% | 3.4M | 13.2 |
| 2026-07-31 | 44.0M | -3.9% | 31.41% | 3.7M | 12.0 |
| 2026-07-15 | 45.8M | -7.0% | 32.67% | 4.7M | 9.8 |
| 2026-06-30 | 49.2M | -2.2% | 35.12% | 6.5M | 7.5 |
| 2026-06-15 | 50.3M | +3.7% | 35.91% | 6.7M | 7.5 |
| 2026-05-29 | 48.5M | -6.4% | 34.62% | 5.3M | 9.2 |
| 2026-05-15 | 51.8M | +19.1% | 37.00% | 6.8M | 7.7 |
| 2026-04-30 | 43.5M | +12.2% | 31.07% | 10.1M | 4.3 |
| 2026-04-15 | 38.8M | -0.3% | 27.70% | 2.5M | 15.4 |
| 2026-03-31 | 38.9M | -1.3% | 27.79% | 3.6M | 10.8 |
| 2026-03-13 | 39.4M | -11.0% | 28.15% | 5.1M | 7.7 |
| 2026-02-27 | 44.3M | -2.1% | 31.62% | 2.6M | 17.3 |
| 2026-02-13 | 45.3M | -0.1% | 32.30% | 3.8M | 11.9 |
| 2026-01-30 | 45.3M | +6.5% | 32.34% | 8.0M | 5.7 |
| 2026-01-15 | 42.6M | +2.4% | 30.37% | 5.6M | 7.5 |
| 2025-12-31 | 41.6M | +2.4% | 29.66% | 3.0M | 13.7 |
| 2025-12-15 | 40.6M | -9.0% | 28.96% | 3.9M | 10.4 |
| 2025-11-28 | 44.6M | +10.8% | 31.81% | 4.7M | 9.5 |
| 2025-11-14 | 40.2M | +3.0% | 28.71% | 9.8M | 4.1 |
| 2025-10-31 | 39.1M | +26.4% | 27.89% | 12.2M | 3.2 |
| 2025-10-15 | 30.9M | +3.9% | 22.05% | 7.4M | 4.2 |
| 2025-09-30 | 29.7M | -12.9% | 21.22% | 8.2M | 3.6 |
| 2025-09-15 | 34.1M | +23.1% | 24.36% | 4.3M | 7.9 |
| 2025-08-29 | 27.7M | +0.0% | 19.79% | 3.7M | 7.6 |
| 2025-08-15 | 27.7M | -6.7% | 19.79% | 4.9M | 5.7 |